We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Label-Free Microscopy Method Enables Faster, Quantitative Detection of Malaria

By LabMedica International staff writers
Posted on 23 Apr 2026

Microscopy of blood smears remains a cornerstone for malaria diagnosis but can be slow, stain-dependent, and operator intensive. More...

With more than 200 million infections and over 600,000 deaths annually, faster and more objective readouts could improve testing workflows and surveillance. Aligning results across laboratories is also challenging when interpretation is subjective. To address this, researchers have introduced a microscopy approach that combines a magnetic field with polarized light to provide quantitative measurements, enabling faster and more objective detection of malaria in blood.

The team, comprising researcher Dickson Mwenda Kinyua of Kirinyaga University in Kenya and Pietro Cicuta with his team at the University of Cambridge, developed a magneto-optical microscopy platform that combines a controlled magnetic field with polarized light to visualize and quantify malaria pigment (hemozoin) in blood. The method is designed to generate objective measurements without the need for staining or chemical treatment and is described in a study in Biomedical Optics Express (2026).

The platform exploits physical properties of hemozoin, which is produced when parasites digest hemoglobin inside red blood cells (RBCs). These crystals are magnetically anisotropic and exhibit optical dichroism, meaning they align in a magnetic field and modulate polarized light in an orientation-dependent manner. Under a polarizing microscope, applying the magnetic field induces measurable intensity and contrast shifts. Ratiometric intensity analysis, which compares image intensity before and after magnetic alignment, combined with threshold-based segmentation, links signal strength to hemozoin concentration and enables quantitative readouts.

Laboratory imaging of blood samples with and without malaria produced a consistent signal that increased linearly with hemozoin content, indicating reliable detection and quantification. The team plans to move from controlled experiments to clinical trials, expand testing across a wider range of patient samples, and compare performance with standard methods. Ongoing work targets simpler, faster operation and integration with image analysis and machine learning to reduce expert dependence and improve consistency. 

“Our method not only makes it possible to see malaria but also allows more precise measurements and the potential to map its location in the sample. This quantitative information could be very useful in laboratories and hospitals, where it could provide a faster, more consistent, and sensitive diagnosis. It could also make it possible to develop automated approaches for diagnosis,” said Dickson Mwenda Kinyua, researcher at Kirinyaga University in Kenya.

“Our method doesn't require expert interpretation and works without needing to stain or chemically treat the sample, making testing more accessible and easier to perform consistently,” said Kinyua. "This could lead to earlier detection, better treatment decisions, and ultimately better health outcomes"

Related Links
Kirinyaga University


Gold Member
STI Test
Vivalytic MG, MH, UP/UU
Online QC Software
Acusera 24•7
New
Food Allergy Screening ELISA Kit
Allerquant 14G B ELISA
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Pathology

view channel
Image: Immune-related signals in routine bone marrow biopsy slides could help predict multiple myeloma outcomes and support more personalized treatment strategies (image credit: Shutterstock)

AI Tool Extracts Immune Signals from Biopsy to Inform Myeloma Therapy

Multiple myeloma is a bone marrow malignancy in which patients can respond very differently to the same treatments, making initial therapy decisions difficult. Clinicians must choose among options such... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.